Neil Brewis, PhD., DSc

2020

In 2020, Neil Brewis, PhD., DSc earned a total compensation of $1.7M as Chief Scientific Officer at F-star Therapeutics.

Compensation breakdown

Bonus$247,500
Option Awards$1,075,000
Salary$320,937
Other$25,965
Total$1,669,402

DSc received $1.1M in option awards, accounting for 64% of the total pay in 2020.

DSc also received $247.5K in bonus, $320.9K in salary and $26K in other compensation.

Rankings

In 2020, Neil Brewis, PhD., DSc's compensation ranked 6,354th out of 13,090 executives tracked by ExecPay. In other words, DSc earned more than 51.5% of executives.

ClassificationRankingPercentile
All
6,354
out of 13,090
52nd
Division
Manufacturing
2,620
out of 5,618
53rd
Major group
Chemicals And Allied Products
1,058
out of 2,251
53rd
Industry group
Drugs
914
out of 1,951
53rd
Industry
Pharmaceutical Preparations
682
out of 1,456
53rd
Source: SEC filing on April 22, 2022.

DSc's colleagues

We found seven more compensation records of executives who worked with Neil Brewis, PhD., DSc at F-star Therapeutics in 2020.

2020

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2020

Neil Brewis

F-star Therapeutics

Chief Scientific Officer

2020

Louis Kayitalire

F-star Therapeutics

Chief Medical Officer

2020

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

2020

RP Iyer

F-star Therapeutics

Chief Scientific Officer

2020

Martin Driscoll

F-star Therapeutics

Chief Executive Officer

2020

Jonathan Freve

F-star Therapeutics

Chief Financial Officer

News

In-depth

You may also like